SR Bornstein, A Schuppenies, ML Wong, J … - Molecular psychiatry, 2006 - manpixforfit.59.to Obesity and depression are serious public health problems and also constitute
cardiovascular disease risk factors. Research organizations have called for
efforts to explore the interrelationship between obesity and depression. A ... Cited by 33 - Related articles - View as HTML - BL Direct - All 8 versions
- ►endojournals.org WL Holland, SA Summers - Endocrine Reviews, 2008 - Endocrine Soc Obesity and dyslipidemia are risk factors for metabolic disorders including
diabetes and cardiovascular disease. Sphingolipids such as ceramide and
glucosylceramides, while being a relatively minor component of the lipid ... Cited by 29 - Related articles - All 7 versions
WS CUTFIELD, PL HOFMAN, M MITCHELL, … - Pediatric research, 2007 - journals.lww.com ABSTRACT: Following Barker's observations of an association between birth size
and later adult diseases, considerable efforts have been made to define the
characteristics of low birth weight groups in childhood. In this review, ... Cited by 16 - Related articles - BL Direct - All 4 versions
R Basu, R Singh, A Basu, CM Johnson, RA … - Diabetes, 2006 - Am Diabetes Assoc The splanchnic bed produces cortisol at rates approximating extraadrenal tissues
by converting cortisone to cortisol via the 11β-hydroxysteroid dehydrogenase
(11β-HSD) type 1 pathway. It is not known whether splanchnic cortisol ... Cited by 16 - Related articles - BL Direct - All 4 versions
- ►endojournals.org Y Liu, C Yan, Y Wang, Y Nakagawa, N Nerio, … - Endocrinology, 2006 - Endocrine Soc The glucocorticoid receptor (GR) is a crucial target gene for
glucocorticoid-induced insulin resistance and hepatic gluconeogenesis linked to
the development of type 2 diabetes. The liver X receptors (LXRs) are ... Cited by 15 - Related articles - BL Direct - All 4 versions
NM Morton, JR Seckl - Obesity and metabolism, 2008 - books.google.com Korbonits M (ed): Obesity and Metabolism. Front Horm Res. Basel, Karger, 2008,
vol 36, pp 146-164 11 p-Hydroxysteroid Dehydrogenase Type 1 and Obesity Nicholas
M. Morton• Jonathan R. Seckl Endocrinology Unit, Centre for ... Cited by 9 - Related articles - BL Direct - All 5 versions
N Neubauer, RN Kulkarni - ILAR JOURNAL, 2006 - dels.nas.edu Type 2 diabetes is a polygenic disease that can lead to severe complications in
multiple tissues. Rodent models have been used widely for investigating the
pathophysiol- ogy underlying type 2 diabetes and for examining the po- ... Cited by 8 - Related articles - View as HTML - BL Direct - All 2 versions
- ►physiology.org AE Coutinho, JE Campbell, S Fediuc, MC … - Journal of Applied Physiology, 2006 - Am Physiological Soc Recent findings indicate that elevated levels of glucocorticoids (GC), governed
by the expression of 11 -hydroxysteroid dehydrogenase type 1 (11 -HSD1) and GC
receptors (GR), in visceral adipose tissue and skeletal muscle lead to ... Cited by 5 - Related articles - BL Direct - All 8 versions
- ►endocrinology-journals.org Y Liu, Y Nakagawa, Y Wang, L Liu, H Du, W … - Journal of Molecular Endocrinology, 2008 - Soc Endocrinology Intracellular glucocorticoid (GC) receptor (GR) function determines tissue
sensitivity to GCs and strongly affects the development of type 2 diabetes and
obesity. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) mediates ... Cited by 5 - Related articles - All 3 versions
- ►endocrinology-journals.org IJ Bujalska, LL Gathercole, JW Tomlinson, C … - Journal of Endocrinology, 2008 - Soc Endocrinology Glucocorticoid excess increases fat mass, preferentially within omental depots;
yet circulating cortisol concentrations are normal in most patients with
metabolic syndrome (MS). At a pre-receptor level, 11β-hydroxysteroid ... Cited by 5 - Related articles - BL Direct - All 12 versions
